Dementia

Dementia is not a specific disease. It is a descriptive term for a collection of symptoms that can be caused by a number of disorders that affect the brain. People with dementia have significantly impaired intellectual functioning that interferes with normal activities and relationships.

What Causes Dementia?

Dementia occurs due to loss of brain function that occurs with certain diseases. It can affect several brain functions such as memory, thinking, language, planning, behavior and judgement. Dementias are usually progressive and worsen with time. They usually are degenerative and non reversible.

Aromatherapy for Dementia

Dementia with Lewy Bodies

What is Dementia?

Transcutaneous Electrical Nerve Stimulation for Dementia

Bright Light Therapy and Dementia

Mixed Dementia Symptoms and Diagnosis

Dementia Symptoms

What is Mixed Dementia?

Coconut Oil and Dementia

Dementia Treatment

Childhood Dementia Causes

See more featured articles »

Parkinson's Compared to Dementia with Lewy Bodies (DLB)

Antidepressants and Dementia: Is There a Link?

Dementia Diagnosis

Dementia Prevention

Differences Between Alzheimer's and Dementia

Childhood Dementia Signs and Symptoms

Mixed Dementia Prevention and Treatment

Migraines and Dementia

Does Depression and Anxiety Increase the Risk of Dementia?

Latest Dementia News and Research

White matter alterations connect coronary artery disease to cognitive decline

Individuals with coronary artery disease (CAD) - a constricting or blocking of blood vessels feeding the heart - face increased risks of strokes, cognitive impairment and dementia. However, the link between CAD and cognitive function is not fully understood.

25 Nov 2025

Study elucidates how anti-amyloid antibody therapy lecanemab works in Alzheimer's disease

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid plaques and delays cognitive decline.

25 Nov 2025

Infection-related hospital stays linked to higher risk of developing dementia

A new research paper was published in Volume 17, Issue 10 of Aging-US on October 13, 2025, titled "Hospitalization with infections and risk of Dementia: a systematic review and meta-analysis."

25 Nov 2025

Scientists uncover how brain enzyme OTULIN controls tau expression

Scientists have uncovered a surprising mechanism by which a brain enzyme called OTULIN controls the expression of tau, the protein that forms toxic tangles in Alzheimer's disease.

25 Nov 2025

Neuroscientists detect five broad phases of brain structure in the average human life

Neuroscientists at the University of Cambridge have identified five "major epochs" of brain structure over the course of a human life, as our brains rewire to support different ways of thinking while we grow, mature, and ultimately decline.

25 Nov 2025

Arginine slows amyloid buildup and improves brain outcomes in Alzheimer’s disease models

Arginine reduced amyloid beta aggregation in vitro and in both Drosophila and AppNL-G-F mouse models of Alzheimer’s disease, leading to fewer dense-core plaques and improved behavior. The study provides preclinical evidence that oral arginine may modulate amyloid pathology, although high dosing requirements and model limitations constrain human translation.

24 Nov 2025

Can diet calm early memory problems? Anti-inflammatory Mediterranean eating shows promise

Older women who follow a strongly anti-inflammatory Mediterranean diet report far fewer subjective memory complaints than those who do not. The AnMED pattern outperforms both traditional Mediterranean and MIND diets, showing a clear advantage for protecting early cognitive symptoms.

24 Nov 2025

New discovery could reshape how scientists think about Alzheimer’s treatment

Rutgers neuroscientist Peng Jiang was visiting his hometown of Qianshan, a city in China's Anhui province, when a neighbor came to his parents' house with a story that would stay with him.

24 Nov 2025

Hearing loss emerges as a key early warning sign for Alzheimer disease

Hearing loss also predicts a significantly higher risk of dementia, especially in APOE ε4 carriers, highlighting its value as an early risk marker.

23 Nov 2025

Does coffee truly boost memory and focus or is it all hype?

Coffee’s bioactive compounds, especially caffeine, show potential cognitive, neuroprotective, and neuroplasticity benefits across animal and human studies. However, most findings are observational, mechanisms remain uncertain, and optimal intake is still unclear.

23 Nov 2025

Oral arginine reduces amyloid buildup in Alzheimer’s models

Alzheimer's disease (AD), a progressive neurodegenerative disorder, is one of the leading causes of dementia worldwide, and currently has no definitive cure. Although antibody-based therapies that target amyloid β (Aβ) have recently been developed, their clinical effectiveness remains limited.

21 Nov 2025

Midlife exercise cuts dementia risk by up to 45 percent, new study shows

Higher physical activity in midlife and late life is linked to a substantially lower risk of all-cause and Alzheimer’s dementia. Midlife benefits are strongest for moderate or heavy activity, while late-life activity is protective across all intensity levels.

20 Nov 2025

Clogged brain drains may signal early Alzheimer's risk

"Drains" in the brain, responsible for clearing toxic waste in the organ, tend to get clogged up in people who show signs of developing Alzheimer's disease, a study by researchers from Nanyang Technological University, Singapore (NTU Singapore) has discovered.

19 Nov 2025

Study links obesity severity to escalating cardiometabolic and renal disease burden

Obesity severity is incrementally associated with a broad range of cardiometabolic and renal disease burden, as discovered by researchers at Pennington Biomedical Research Center. Recently published in Obesity, the paper "Association of Obesity Severity with Cardiometabolic and Renal Disease Burden in the United States," explored the relationship through a cross-sectional study of data from the U.S. Behavioral Risk Factor Surveillance System survey.

18 Nov 2025

Scottish Brain Sciences opens new Alzheimer’s clinical research center at ONE Biohub

Scottish Brain Sciences (SBS), a leading clinical research organization dedicated to transforming the early detection and treatment of Alzheimer's disease and other neurodegenerative conditions, today announced that it has opened a new state-of-the-art clinical research center at ONE BioHub, Aberdeen.

17 Nov 2025

Study reveals widespread use of burdensome interventions for older dementia patients in Singapore

A new study by researchers from Duke-NUS Medical School has revealed that almost all community-dwelling older adults with advanced dementia in Singapore experience at least one potentially burdensome intervention in their last year of life.

17 Nov 2025

Reclassifying wine intake reshapes the Mediterranean diet’s cognitive impact

Higher adherence to the Mediterranean diet was not associated with better cognition when wine was scored as a “beneficial” component. When wine was reverse scored, Mediterranean diet adherence showed a modest positive association with MMSE performance and a borderline link with MoCA in Portuguese older adults at high dementia risk.

17 Nov 2025

New insights into glioblastoma survival linked to brain fluid dynamics

Glioblastoma-the most aggressive form of brain cancer-remains one of medicine's biggest challenges. Despite surgery, radiotherapy, and chemotherapy, most patients survive only about a year after diagnosis.

14 Nov 2025

Empowering early detection of dementia with a dual approach involving AI and patient input

Few primary care practices are designed for the timely detection of Alzheimer's disease and related dementias. The limited time that primary care clinicians are able to spend with patients, the need to focus on the health problems which brought the patient to the clinic, as well as the stigma of Alzheimer's disease and dementia are major reasons for lack of recognition of the condition.

13 Nov 2025

TRIMTECH Therapeutics appoints Dr Mike Hutton to Scientific Advisory Board

TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, today announced the appointment of Dr Mike Hutton to its Scientific Advisory Board (SAB).

From TRIMTECH Therapeutics 12 Nov 2025